Karyopharm therapeutics inc. reports earnings results for the third quarter ended september 30, 2019

Karyopharm therapeutics inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 13.149 million compared to usd 239,000 a year ago. operating loss was usd 39.401 million compared to usd 49.154 million a year ago. net loss was usd 41.367 million compared to usd 48.083 million a year ago. basic loss per share was usd 0.67 compared to usd 0.79 a year ago. for the nine months, total revenue was usd 22.797 million compared to usd 30.130 million a year ago. operating loss was usd 146.009 million compared to usd 122.428 million a year ago. net loss was usd 150.943 million compared to usd 120.197 million a year ago. basic loss per share was usd 2.46 compared to usd 2.17 a year ago.
KPTI Ratings Summary
KPTI Quant Ranking